Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Heart Failure
and you are
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this registry (NCT02876042) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO system in the commercial setting in subjects recently implanted under the CE-Marked indication for resistant hypertension that also have evidence of heart failure with preserved ejection fraction (HFpEF).

Provided treatments

  • Device: BAROSTIM NEO™ System
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02876042. The sponsor of the trial is CVRx, Inc. and it is looking for 70 volunteers for the current phase.
Official trial title:
BAROSTIM THERAPY ™ in Heart Failure With Preserved Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System